Fatty acid binding protein 3 as a potential mediator for diabetic nephropathy in eNOS deficient mouse
- PMID: 25450688
- DOI: 10.1016/j.bbrc.2014.10.121
Fatty acid binding protein 3 as a potential mediator for diabetic nephropathy in eNOS deficient mouse
Abstract
In human diabetic nephropathy, glomerular injury was found to comprise lipid droplets, suggesting that abnormal lipid metabolism might take place in the development of diabetic glomerular injury. However, its precise mechanism remains unclear. Fatty acid binding protein (FABP) is currently considered as a key molecule for lipid metabolism. Since diabetic eNOS knockout (KO) mouse is considered to be a good model for human diabetic nephropathy, we here investigated whether FABP could mediate glomerular injury in this model. We found that glomerular injuries were associated with inflammatory processes, such as macrophage infiltration and MCP-1 induction. Microarray assay with isolated glomeruli revealed that among 10 isoforms in FABP family, FABP3 mRNA was most highly expressed in diabetic eNOSKO mice compared to non-diabetic eNOSKO mice. FABP3 protein was found to be located in the mesangial cells. Overexpression of FABP3 resulted in a greater response to palmitate, a satulated FA, to induce MCP-1 in the rat mesangial cells. In turn, the heart, a major organ for FABP3 protein in normal condition, failed to alter its expression level under diabetic condition in either wild type or eNOSKO mice. In conclusion, FABP3 is induced in the mesangial cells and likely a mediator to induce MCP-1 in the diabetic nephropathy.
Keywords: Advanced diabetic nephropathy; Endothelial; FABP; Fatty acid; Inflammation; Nitric oxide.
Copyright © 2014 The Authors. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Protective effects of tubular liver-type fatty acid-binding protein against glomerular damage in murine IgA nephropathy.Nephrol Dial Transplant. 2011 Jul;26(7):2127-37. doi: 10.1093/ndt/gfq687. Epub 2010 Nov 25. Nephrol Dial Transplant. 2011. PMID: 21109611
-
Deficiency of endothelial nitric-oxide synthase confers susceptibility to diabetic nephropathy in nephropathy-resistant inbred mice.Am J Pathol. 2007 May;170(5):1473-84. doi: 10.2353/ajpath.2007.060481. Am J Pathol. 2007. PMID: 17456755 Free PMC article.
-
Inhibition of kidney proximal tubular glucose reabsorption does not prevent against diabetic nephropathy in type 1 diabetic eNOS knockout mice.PLoS One. 2014 Nov 4;9(11):e108994. doi: 10.1371/journal.pone.0108994. eCollection 2014. PLoS One. 2014. PMID: 25369239 Free PMC article.
-
A new mouse model resembling human diabetic nephropathy: uncoupling of VEGF with eNOS as a novel pathogenic mechanism.Clin Nephrol. 2009 Feb;71(2):103-9. doi: 10.5414/cnp71103. Clin Nephrol. 2009. PMID: 19203501 Review.
-
Endothelial nitric oxide synthase.Contrib Nephrol. 2011;170:93-101. doi: 10.1159/000324954. Epub 2011 Jun 9. Contrib Nephrol. 2011. PMID: 21659762 Review.
Cited by
-
Myokines: Novel therapeutic targets for diabetic nephropathy.Front Endocrinol (Lausanne). 2022 Oct 25;13:1014581. doi: 10.3389/fendo.2022.1014581. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36387916 Free PMC article. Review.
-
Urinary Fatty Acid Binding Protein 3 Has Prognostic Value in Peripheral Artery Disease.Front Cardiovasc Med. 2022 Jun 20;9:875244. doi: 10.3389/fcvm.2022.875244. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35795372 Free PMC article.
-
Downregulation of low-density lipoprotein receptor mRNA in lymphatic endothelial cells impairs lymphatic function through changes in intracellular lipids.Theranostics. 2022 Jan 1;12(3):1440-1458. doi: 10.7150/thno.58780. eCollection 2022. Theranostics. 2022. PMID: 35154499 Free PMC article.
-
Association of plasma fatty acid-binding protein 3 with estimated glomerular filtration rate in patients with type 2 diabetes mellitus.Int J Med Sci. 2022 Jan 1;19(1):82-88. doi: 10.7150/ijms.66876. eCollection 2022. Int J Med Sci. 2022. PMID: 34975301 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous
